Cytological analysis and immunocytochemical expression of Ki67 and Bcl-2 in breast proliferative lesions

Anticancer Research

Volumn 22, Issue 2 B, 2002, Pages 1341-1345

  Midulla, Cecilia ^a   Pisani, Tiziana ^a   De Iorio, Piera ^a   Cenci, Maria ^a   Divizia, Emanuela ^a   Nofroni, Italo ^a   Vecchione, Aldo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bcl 2; Breast proliferative lesions; Ki67

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2;

ARTICLE; ASPIRATION CYTOLOGY; BREAST LESION; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CHROMATIN CONDENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

AGED; BIOPSY, NEEDLE; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; GRANULOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PAPILLOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES;

EID: 0036326414     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The role of pre-operative diagnosis in breast cancer
2. Breast malignancy
3. The value of needle aspiration cytology of the breast with emphasis on the diagnosis in young women below the age of 30
4. Preoperative aspiration cytology of breast tumors
5. The triage role of fine needle aspiration biopsy of palpable breast masses: Diagnostic accuracy and cost-effectiveness
6. Sterotactic fine-needle aspiration biopsy for the evaluation of nonpalpable breast lesions: Report of an experience based on 2,988 cases
7. Breast fine needle aspiration cytology: Utility as a screening tool for clinically palpable lesions
8. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ
9. The spectrum of the "Gray Zone" in breast cytology: A review of 186 cases of atypical and suspicious cytology
10. Fine needle aspiration of the breast: Diagnoses and pitfalls. A review of 3545 cases
11. The cytopathology of proliferative breast disease. Comparison with features of ductal carcinoma in situ
12. The value of fine needle aspiration cytology in the diagnosis of breast proliferative lesions
13. Atypia in breast fine needle aspiration smears correlate poorly with the presence of a prognostically significant proliferative lesion of ductal epithelium
14. Can non proliferative breast disease and proliferative breast disease without atypia be distinguished by fine needle aspiration cytology?
15. Equivocal diagnoses in breast aspiration biopsy cytology: Sources of uncertainty and the role of atypical/indeterminate terminology
16. The cell proliferation-associated antigen of antibody Ki67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins
17. Prognostic value of Ki67 immunolabeling in primary operable breast cancer
18. Proliferation index as a prognostic marker in breast cancer
19. Apoptosis. Its significance in cancer and cancer therapy
20. Expression of the bcl-2 gene family in normal and in malignant breast tissue: Low bax-alfa expression in tumor cells correlates with resistance towards apoptosis
21. Probabilistic approach to the reporting of fine-needle aspiration cytology of the breast
22. Monoclonal antibody Ki-67: Its use in histopathology
23. c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and non-invasive breast carcinoma
24. Breast cancer kinetics: Immunohistochemical determination of growth fraction by monoclonal antibody Ki67 and correlation with flow-cytometric S-phase and with some features of tumour aggressiveness
25. Comparison between Ki67 index and S-phase fraction on fine-needle aspiration sample from breast carcinoma
26. Ki-67 immunostaining in primary breasr cancer: Pathological and clinical associations
27. Bcl-2 slow in vitro breast cancer growth despite its antiapoptotic effect
28. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cells death, but also with increased proliferative activity
29. bcl-2 protein expression and long-term survival in breast cancer
30. bcl-2 expression in normal breast tissue during the menstrual cycle